Finnrick, an independent testing programme, publishes 4 assays for GrayPep, and all 4 that it grades met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation). Most recent assay 11 May 2026.
GrayPep listed by Finnrick as "Trading". Source: Finnrick, https://www.finnrick.com/vendors/graypep.
GrayPep is listed as active.
| Product | Assays | Result |
|---|---|---|
| Tirzepatide | 4 | 4 passed, 0 failed |
Source: Finnrick, as published 2026-08-09. Pass and fail are Finnrick's classification against its own threshold, not ours.
| Status | Active |
|---|---|
| Vendor type | Research-use supplier |
These details were read from GrayPep's own website on 2026-08-19. Pages consulted:
GrayPep is listed as active and we hold 4 Finnrick assays (4 passing, 0 failing its purity threshold). That is evidence about the batches that were tested or published, not a guarantee about the vial you receive.
Yes. Finnrick, an independent testing programme, publishes 4 assays for GrayPep, and all 4 that it grades met its Purity focus threshold (at least 99.5% purity, no more than 35% dosage deviation). Most recent assay 11 May 2026.
Popular peptides: Semaglutide, Tirzepatide, Retatrutide, BPC-157, CJC-1295, Ipamorelin.
Other reviewed vendors: Great Basin Bio Supply Peptides Review, Great Lakes Peptides Review, Great Life Peptides Review.